These results convincingly indicate that dysfunctional SOX4 contributes to the molecular pathogenesis of CHD in the mutation carriers and may help to provide SOX4 gene-related diagnosis and treatment strategies for CHD patients harboring SOX4 mutations. The gene discussed is SOX4; the disease is coronary artery disorder.